{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T22:55:00Z","timestamp":1774133700431,"version":"3.50.1"},"reference-count":248,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence suggests that patients with schizophrenia (SZ) experience an acceleration of the typical aging process. However, it is unclear whether this process reflects premature aging in early life or accelerated aging in later years. Nevertheless, although the timing of accelerated aging in SZ is unclear, there is a consensus that this process is characterized by dysfunctions in immune-oxidative pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>It is a critical need to understand the mechanisms and trajectory of aging underlying SZ so we can target interventions earlier to the right mechanisms. This paper aims to review the recent literature regarding brain energy metabolism in aging with SZ, mainly focusing on the dysfunctions in immuno-oxidative pathway, limitations of studying aging in SZ, and perspective strategies for future studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most studies reviewed in this paper point toward age-related metabolic and cognitive alterations in individuals with SZ. There are complex relationships between normative aging processes and those in SZ. However, the available data neither definitively reveal when this acceleration occurs within the life span nor attribute premature onset of aging-related changes solely to a diagnosis of SZ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Immuno-oxidative pathway dysregulation represents convergent processes underlying the pathophysiology of both SZ and aging, contributing to synaptic dysfunction, neuronal damage, and cognitive impairment. Further research in this domain, using an innovative accelerated longitudinal design and novel, advanced neuroimaging techniques, might open new avenues for understanding common pathophysiological mechanisms and developing therapeutic interventions targeting these interconnected pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbaf099","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:40:42Z","timestamp":1748504442000},"source":"Crossref","is-referenced-by-count":2,"title":["Aging in Schizophrenia: Perspectives on Molecular Mechanisms and a Mini-review"],"prefix":"10.1093","volume":"52","author":[{"given":"Akila","family":"Weerasekera","sequence":"first","affiliation":[{"name":"Psychotic Disorders Division, McLean Hospital , Belmont, MA 02478 ,","place":["United States"]},{"name":"McLean Imaging Center, McLean Hospital , Belmont, MA 02478 ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6ng\u00fcr","family":"Dost","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division, McLean Hospital , Belmont, MA 02478 ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0446-7604","authenticated-orcid":false,"given":"Du","family":"Fei","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division, McLean Hospital , Belmont, MA 02478 ,","place":["United States"]},{"name":"McLean Imaging Center, McLean Hospital , Belmont, MA 02478 ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,6]]},"reference":[{"key":"2026032106202889500_CIT0001","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12888-015-0562-2","article-title":"Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses","volume":"15","author":"Laurens","year":"2015","journal-title":"BMC Psychiatry."},{"key":"2026032106202889500_CIT0002","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0004867415623858","article-title":"Brain gray matter alterations and associated demographic profiles in adults with autism spectrum disorder: a meta-analysis of voxel-based morphometry studies","volume":"50","author":"Yang","year":"2016","journal-title":"Aust N Z J Psychiatry."},{"key":"2026032106202889500_CIT0003","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.4088\/JCP.14m09369","article-title":"How age and gender predict illness course in a first-episode nonaffective psychosis cohort","volume":"77","author":"Drake","year":"2016","journal-title":"J Clin Psychiatry."},{"key":"2026032106202889500_CIT0004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajmg.b.32814","article-title":"Why does age of onset predict clinical severity in schizophrenia? A multiplex extended pedigree study","volume":"183","author":"Musket","year":"2020","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"2026032106202889500_CIT0005","first-page":"37","article-title":"Why sex differences in schizophrenia","volume":"1","author":"Li","year":"2016","journal-title":"J Transl Neurosci (Beijing)"},{"key":"2026032106202889500_CIT0006","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/BF02190734","article-title":"Epidemiology of early-onset schizophrenia","volume":"245","author":"Hafner","year":"1995","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"2026032106202889500_CIT0007","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/schbul\/14.1.39","article-title":"Late-onset schizophrenia: an overview","volume":"14","author":"Harris","year":"1988","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0008","first-page":"2168","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"Electronic"},{"key":"2026032106202889500_CIT0009","doi-asserted-by":"publisher","first-page":"102294","DOI":"10.1016\/j.eclinm.2023.102294","article-title":"Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis","volume":"65","author":"Chan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026032106202889500_CIT0010","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41586-024-07109-5","article-title":"A concerted neuron-astrocyte program declines in ageing and schizophrenia","volume":"627","author":"Ling","year":"2024","journal-title":"Nature."},{"key":"2026032106202889500_CIT0011","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/s0006-3223(98)00273-x","article-title":"Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients","volume":"45","author":"Harvey","year":"1999","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0012","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/archpsyc.58.1.24","article-title":"Stability and course of neuropsychological deficits in schizophrenia","volume":"58","author":"Heaton","year":"2001","journal-title":"Arch Gen Psychiatry."},{"key":"2026032106202889500_CIT0013","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1176\/jnp.15.1.45","article-title":"Are late-onset schizophrenia spectrum disorders neurodegenerative conditions? Annual rates of change on two dementia measures","volume":"15","author":"Palmer","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"2026032106202889500_CIT0014","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/jamapsychiatry.2015.1546","article-title":"Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study","volume":"72","author":"Ribe","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"2026032106202889500_CIT0015","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archpsyc.55.3.205","article-title":"Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases","volume":"55","author":"Purohit","year":"1998","journal-title":"Arch Gen Psychiatry."},{"key":"2026032106202889500_CIT0016","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0006-3223(95)00066-6","article-title":"Neuropeptide deficits in schizophrenia vs. Alzheimer\u2019s disease cerebral cortex","volume":"39","author":"Gabriel","year":"1996","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0017","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/ijerph20010737","article-title":"Subjective overview of accelerated aging in schizophrenia","volume":"20","author":"Seeman","year":"2022","journal-title":"Int J Environ Res Public Health."},{"key":"2026032106202889500_CIT0018","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pscychresns.2013.05.003","article-title":"Age-related brain trajectories in schizophrenia: a systematic review of structural MRI studies","volume":"214","author":"Chiapponi","year":"2013","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0019","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1176\/appi.ajp.2015.15070922","article-title":"Accelerated brain aging in schizophrenia: a longitudinal pattern recognition study","volume":"173","author":"Schnack","year":"2016","journal-title":"Am J Psychiatry."},{"key":"2026032106202889500_CIT0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2016.06.002","article-title":"Patterns of regional gray matter loss at different stages of schizophrenia: a multisite, cross-sectional VBM study in first-episode and chronic illness","volume":"12","author":"Torres","year":"2016","journal-title":"Neuroimage Clin"},{"key":"2026032106202889500_CIT0021","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/0891988713516544","article-title":"Neuroimaging findings in late-onset schizophrenia and bipolar disorder","volume":"27","author":"Hahn","year":"2014","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"2026032106202889500_CIT0022","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41380-022-01897-w","article-title":"Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium","volume":"28","author":"Constantinides","year":"2023","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0023","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/schbul\/sbx069","article-title":"Systemic biomarkers of accelerated aging in schizophrenia: a critical review and future directions","volume":"44","author":"Nguyen","year":"218","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0024","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.biopsych.2023.10.023","article-title":"Accelerated pace of aging in schizophrenia: five case-control studies","volume":"95","author":"Caspi","year":"2024","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0025","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0074-7742(04)59019-0","article-title":"NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia","volume":"59","author":"Coyle","year":"2004","journal-title":"Int Rev Neurobiol."},{"key":"2026032106202889500_CIT0026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","article-title":"The glutamatergic dysfunction hypothesis for schizophrenia","volume":"3","author":"Coyle","year":"1996","journal-title":"Harv Rev Psychiatry."},{"key":"2026032106202889500_CIT0027","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"2026032106202889500_CIT0028","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1523\/jneurosci.16-06-02034.1996","article-title":"NMDA-dependent modulation of CA1 local circuit inhibition","volume":"16","author":"Grunze","year":"1996","journal-title":"J Neurosci."},{"key":"2026032106202889500_CIT0029","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"Do","year":"2009","journal-title":"Curr Opin Neurobiol."},{"key":"2026032106202889500_CIT0030","first-page":"1873","article-title":"Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine","volume":"73","author":"Cabungcal","year":"2013","journal-title":"Electronic"},{"key":"2026032106202889500_CIT0031","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-analysis of oxidative stress in schizophrenia","volume":"74","author":"Flatow","year":"2013","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0032","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0033","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.neuron.2014.07.028","article-title":"Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia","volume":"83","author":"Cabungcal","year":"2014","journal-title":"Neuron."},{"key":"2026032106202889500_CIT0034","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuron.2014.08.028","article-title":"Is prophylactic psychiatry around the corner? Combating adolescent oxidative stress for adult psychosis and schizophrenia","volume":"83","author":"Sawa","year":"2014","journal-title":"Neuron."},{"key":"2026032106202889500_CIT0035","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/157015911795596595","article-title":"Oxidative stress in schizophrenia","volume":"9","author":"Boskovic","year":"2011","journal-title":"Curr Neuropharmacol."},{"key":"2026032106202889500_CIT0036","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1089\/ars.2010.3603","article-title":"Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"2026032106202889500_CIT0037","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sbu053","article-title":"Impaired metabolic reactivity to oxidative stress in early psychosis patients","volume":"40","author":"Fournier","year":"2014","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0038","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/mp.2017.89","article-title":"Investigating the neuroimmunogenic architecture of schizophrenia","volume":"23","author":"Birnbaum","year":"2018","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0039","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-244X-7-46","article-title":"Inflammation-related genes up-regulated in schizophrenia brains","volume":"7","author":"Saetre","year":"2007","journal-title":"BMC Psychiatry"},{"key":"2026032106202889500_CIT0040","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/15622975.2010.530690","article-title":"Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study","volume":"12","author":"Schmitt","year":"2011","journal-title":"World J Biol Psychiatry"},{"key":"2026032106202889500_CIT0041","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1038\/tp.2017.4","article-title":"Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies","volume":"7","author":"Van Kesteren","year":"2017","journal-title":"Transl Psychiatry."},{"key":"2026032106202889500_CIT0042","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"21","author":"Tr\u00e9panier","year":"2016","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0043","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2014.06.021","article-title":"Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a \u201ccentral hub\u201d in schizophrenia pathophysiology","volume":"176","author":"Steullet","year":"2016","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0044","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.biopsych.2014.12.026","article-title":"Prolonged period of cortical plasticity upon redox dysregulation in fast-spiking interneurons","volume":"78","author":"Morishita","year":"2015","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/mp.2014.88","article-title":"Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients","volume":"20","author":"Monin","year":"2015","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0046","first-page":"1428","article-title":"Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models","volume":"20","author":"Kulak","year":"2013","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0047","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.schres.2022.03.005","article-title":"Schizophrenia: a developmental disorder with a risk of non-specific but avoidable decline","volume":"243","author":"Murray","year":"2022","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0048","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.pa.30.040190.000403","article-title":"Excitotoxic amino acids and neuropsychiatric disorders","volume":"30","author":"Olney","year":"1990","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"2026032106202889500_CIT0049","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.2741\/a368","article-title":"The aging of the NMDA receptor complex","volume":"3","author":"Magnusson","year":"1998","journal-title":"Front Biosci."},{"key":"2026032106202889500_CIT0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry."},{"key":"2026032106202889500_CIT0051","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00000542-198202000-00007","article-title":"Ketamine\u2014its pharmacology and therapeutic uses","volume":"56","author":"White","year":"1982","journal-title":"Anesthesiology."},{"key":"2026032106202889500_CIT0052","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/BF03011442","article-title":"An update on the first twenty-five years of clinical experience","volume":"36","author":"Reich","year":"1989","journal-title":"Can J Anaesth."},{"key":"2026032106202889500_CIT0053","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1196\/annals.1300.008","article-title":"The NMDA receptor hypofunction model of psychosis","volume":"1003","author":"Farber","year":"2003","journal-title":"Ann N Y Acad Sci."},{"key":"2026032106202889500_CIT0054","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/mp.2013.136","article-title":"Imaging glutamate in schizophrenia: review of findings and implications for drug discovery","volume":"19","author":"Poels","year":"2014","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0055","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology."},{"key":"2026032106202889500_CIT0056","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1097\/00001756-199608120-00040","article-title":"NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia","volume":"7","author":"Humphries","year":"1996","journal-title":"Neuroreport."},{"key":"2026032106202889500_CIT0057","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1046\/j.1471-4159.1998.71062454.x","article-title":"Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of \u201cneuroleptic-free\u201d schizophrenics: evidence on reversible up-regulation by typical neuroleptics","volume":"71","author":"Sokolov","year":"1998","journal-title":"J Neurochem."},{"key":"2026032106202889500_CIT0058","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1176\/appi.ajp.157.7.1141","article-title":"Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia","volume":"157","author":"Gao","year":"2000","journal-title":"Am J Psychiatry."},{"key":"2026032106202889500_CIT0059","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1176\/appi.ajp.157.11.1811","article-title":"Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia","volume":"157","author":"Ibrahim","year":"2000","journal-title":"Am J Psychiatry."},{"key":"2026032106202889500_CIT0060","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","article-title":"Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses","volume":"12","author":"Law","year":"2001","journal-title":"Neuroreport."},{"key":"2026032106202889500_CIT0061","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/sj.npp.1301604","article-title":"Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder","volume":"33","author":"Beneyto","year":"2008","journal-title":"Neuropsychopharmacology."},{"key":"2026032106202889500_CIT0062","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/mp.2012.137","article-title":"Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia","volume":"18","author":"Weickert","year":"2013","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0063","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0064","doi-asserted-by":"publisher","first-page":"115064","DOI":"10.1016\/j.psychres.2023.115064","article-title":"Bridging the gaps towards precision psychiatry: mechanistic biomarkers for early detection and intervention","volume":"321","author":"Do","year":"2023","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0065","doi-asserted-by":"crossref","DOI":"10.1201\/9781420005523-8","article-title":"Subtle alterations in glutamatergic synapses underlie the aging-related decline in hippocampal function","volume-title":"Brain Aging: Models, Methods, and Mechanisms. Frontiers in Neuroscience","author":"Shi","year":"2007"},{"key":"2026032106202889500_CIT0066","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnagi.2010.00011","article-title":"Selective vulnerabilities of N-methyl-D-aspartate (NMDA) receptors during brain aging","volume":"2","author":"Magnusson","year":"2010","journal-title":"Front Aging Neurosci."},{"key":"2026032106202889500_CIT0067","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol Neurobiol."},{"key":"2026032106202889500_CIT0068","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.10-11-03531.1990","article-title":"Hippocampal representation in place learning","volume-title":"J Neurosci.","author":"Eichenbaum"},{"key":"2026032106202889500_CIT0069","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0166-4328(82)90052-3","article-title":"Selective effects of hippocampal and frontal cortex lesions on a spatial learning problem in two inbred strains of mice","volume":"5","author":"Ammassari-Teule","year":"1982","journal-title":"Behav Brain Res."},{"key":"2026032106202889500_CIT0070","doi-asserted-by":"publisher","first-page":"79","DOI":"10.31887\/DCNS.2001.3.2\/hcourvoisie","article-title":"Psychosis in children: diagnosis and treatment","volume":"3","author":"Courvoisie","year":"2001","journal-title":"Dialogues Clin Neurosci."},{"key":"2026032106202889500_CIT0071","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.chc.2019.08.017","article-title":"Childhood-onset schizophrenia and early-onset schizophrenia spectrum disorders: an update","volume":"29","author":"Driver","year":"2020","journal-title":"Child Adolesc Psychiatr Clin N Am."},{"key":"2026032106202889500_CIT0072","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/BF00967446","article-title":"Age-dependent loss of NMDA receptors in hippocampus, striatum, and frontal cortex of the rat: prevention by acetyl-L-carnitine","volume":"19","author":"Castorina","year":"1994","journal-title":"Neurochem Res."},{"key":"2026032106202889500_CIT0073","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"2026032106202889500_CIT0074","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbr069","article-title":"Glutamate in schizophrenia: a focused review and meta-analysis of (1)H-MRS studies","volume":"39","author":"Marsman","year":"2013","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0075","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0140-6736(03)14289-4","article-title":"Oligodendrocyte dysfunction in schizophrenia and bipolar disorder","volume":"362","author":"Tkachev","year":"2003","journal-title":"Lancet."},{"key":"2026032106202889500_CIT0076","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/sj.mp.4002011","article-title":"Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia","volume":"13","author":"Hashimoto","year":"2008","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0077","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci Biobehav Rev."},{"key":"2026032106202889500_CIT0078","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.schres.2016.10.021","article-title":"Toward understanding thalamocortical dysfunction in schizophrenia through computational models of neural circuit dynamics","volume":"180","author":"Murray","year":"2017","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0079","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.biopsych.2015.06.026","article-title":"Mapping thalamocortical functional connectivity in chronic and early stages of psychotic disorders","volume":"79","author":"Woodward","year":"2016","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0080","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fnsys.2015.00190","article-title":"Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease","volume":"9","author":"Sigurdsson","year":"2015","journal-title":"Front Syst Neurosci."},{"key":"2026032106202889500_CIT0081","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/archpsyc.60.5.443","article-title":"White matter changes in schizophrenia: evidence for myelin-related dysfunction","volume":"60","author":"Davis","year":"2003","journal-title":"Arch Gen Psychiatry."},{"key":"2026032106202889500_CIT0082","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/brain\/124.5.882","article-title":"Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging","volume":"124","author":"Foong","year":"2001","journal-title":"Brain."},{"key":"2026032106202889500_CIT0083","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.biopsych.2011.02.022","article-title":"Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia","volume":"70","author":"Sodhi","year":"2011","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0084","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.bionps.2020.100015","article-title":"Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: insights for rational biomarker development","volume":"3","author":"Schoonover","year":"2020","journal-title":"Biomark Neuropsychiatry"},{"key":"2026032106202889500_CIT0085","first-page":"2145","article-title":"Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre (1)H-MRS study (OPTiMiSE)","volume-title":"Mol Psychiatry","author":"Egerton","year":"2018"},{"key":"2026032106202889500_CIT0086","first-page":"533","article-title":"Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume","volume-title":"Biol Psychiatry","author":"Stone","year":"2009"},{"key":"2026032106202889500_CIT0087","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mp.2009.121","article-title":"1H-MRS at 4 tesla in minimally treated early schizophrenia","volume":"15","author":"Bustillo","year":"2010","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0088","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/archpsyc.1997.01830220085012","article-title":"Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy","volume":"54","author":"Bartha","year":"1997","journal-title":"Arch Gen Psychiatry."},{"key":"2026032106202889500_CIT0089","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/jamapsychiatry.2021.0380","article-title":"Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of individual participant-level data","volume":"78","author":"Merritt","year":"2021","journal-title":"JAMA Psychiatry."},{"key":"2026032106202889500_CIT0090","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.schres.2004.08.021","article-title":"Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study","volume":"73","author":"Ohrmann","year":"2005","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0091","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jpsychires.2006.07.002","article-title":"Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study","volume":"41","author":"Ohrmann","year":"2007","journal-title":"J Psychiatr Res."},{"key":"2026032106202889500_CIT0092","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/schbul\/sbt124","article-title":"Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia","volume":"40","author":"Natsubori","year":"2014","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0093","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/mp.2008.87","article-title":"Proton MRS in twin pairs discordant for schizophrenia","volume":"15","author":"Lutkenhoff","year":"2010","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0094","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.schres.2008.11.014","article-title":"Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)","volume":"108","author":"Tayoshi","year":"2009","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0095","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1176\/appi.ajp.160.12.2231","article-title":"Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS","volume":"160","author":"Theberge","year":"2003","journal-title":"Am J Psychiatry."},{"key":"2026032106202889500_CIT0096","first-page":"101","article-title":"Age-related changes in anterior cingulate cortex glutamate in schizophrenia: a (1)H MRS Study at 7 Tesla","volume-title":"Schizophr Res.","author":"Brandt","year":"2016"},{"key":"2026032106202889500_CIT0097","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1038\/npp.2015.57","article-title":"Evaluation of myo-inositol as a potential biomarker for depression in schizophrenia","volume-title":"Neuropsychopharmacol","author":"Chiappelli","year":"2015"},{"key":"2026032106202889500_CIT0098","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/npp.2016.172","article-title":"Altered glutamate and regional cerebral blood flow levels in schizophrenia: a (1)H-MRS and pCASL study","volume":"42","author":"Wijtenburg","year":"2017","journal-title":"Neuropsychopharmacology."},{"key":"2026032106202889500_CIT0099","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1126\/science.1835799","article-title":"NMDA antagonist neurotoxicity: mechanism and prevention","volume":"254","author":"Olney","year":"1991","journal-title":"Science."},{"key":"2026032106202889500_CIT0100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2008.11.021","article-title":"Meta-analysis of diffusion tensor imaging studies in schizophrenia","volume":"108","author":"Ellison-Wright","year":"2009","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0101","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1176\/appi.ajp.162.3.602","article-title":"White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study","volume":"162","author":"Szeszko","year":"2005","journal-title":"Am J Psychiatry."},{"key":"2026032106202889500_CIT0102","doi-asserted-by":"crossref","article-title":"3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia","author":"Tibbo","DOI":"10.1176\/appi.ajp.161.6.1116"},{"key":"2026032106202889500_CIT0103","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-244X-5-6","article-title":"Elevated glutamine\/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients","volume":"5","author":"Hashimoto","year":"2005","journal-title":"BMC Psychiatry."},{"key":"2026032106202889500_CIT0104","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/npp.2011.65","article-title":"Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis","volume":"36","author":"de la Fuente-Sandoval","year":"2011","journal-title":"Neuropsychopharmacology."},{"key":"2026032106202889500_CIT0105","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","article-title":"Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies","volume":"73","author":"Merritt","year":"2016","journal-title":"JAMA Psychiatry."},{"key":"2026032106202889500_CIT0106","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/mp.2014.54","article-title":"Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia","volume":"20","author":"Stan","year":"2015","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0107","doi-asserted-by":"publisher","first-page":"104920","DOI":"10.1016\/j.dib.2019.104920","article-title":"Supplementary data for a focused review and meta-analysis of (1)H-MRS studies on cerebral glutamate and GABA levels in high-risk of psychosis states","volume":"28","author":"Wenneberg","year":"2020","journal-title":"Data Brief"},{"key":"2026032106202889500_CIT0108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2012.12.019","article-title":"Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia","volume":"144","author":"Shan","year":"2013","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0109","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/npp.2010.252","article-title":"Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia","volume":"36","author":"Katsel","year":"2011","journal-title":"Neuropsychopharmacology."},{"key":"2026032106202889500_CIT0110","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coph.2006.08.013","article-title":"NMDA receptors and schizophrenia","volume":"7","author":"Kristiansen","year":"2007","journal-title":"Curr Opin Pharmacol."},{"key":"2026032106202889500_CIT0111","article-title":"Brain energy metabolism and catecholaminergic activity in hypoxia, hypercapnia and ischemia","author":"Siesj\u00f6"},{"key":"2026032106202889500_CIT0112","first-page":"643","article-title":"Circulatory and metabolic correlates of brain function in normal humans","volume":"643","author":"Raichle","year":"2011","journal-title":"Comprehens Physiol"},{"key":"2026032106202889500_CIT0113","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1073\/pnas.95.1.316","article-title":"Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity","volume":"95","author":"Sibson","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"2026032106202889500_CIT0114","doi-asserted-by":"publisher","first-page":"8235","DOI":"10.1073\/pnas.96.14.8235","article-title":"Determination of the rate of the glutamate\/glutamine cycle in the human brain by in vivo 13C NMR","volume":"96","author":"Shen","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2026032106202889500_CIT0115","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tins.2004.06.005","article-title":"Energetic basis of brain activity: implications for neuroimaging","volume":"27","author":"Shulman","year":"2004","journal-title":"Trends Neurosci."},{"key":"2026032106202889500_CIT0116","article-title":"Physiology, adenosine triphosphate","author":"Dunn","year":"2024","journal-title":"StatPearls."},{"key":"2026032106202889500_CIT0117","first-page":"804","article-title":"[Biochemical aspects of cerebral aging. Role of oxygen]. Aspects biochimiques du vieillissement cerebral. Role de l\u2019oxygene","volume":"12","author":"Sebban","year":"1983","journal-title":"Presse Med."},{"key":"2026032106202889500_CIT0118","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/geronj\/11.3.298","article-title":"Aging: a theory based on free radical and radiation chemistry","volume":"11","author":"Harman","year":"1956","journal-title":"J Gerontol"},{"key":"2026032106202889500_CIT0119","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00424-021-02531-4","article-title":"Interplay between bioenergetics and oxidative stress at normal brain aging. Aging as a result of increasing disbalance in the system oxidative stress-energy provision","volume":"473","author":"Lushchak","year":"2021","journal-title":"Pflugers Arch."},{"key":"2026032106202889500_CIT0120","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/s41380-022-01494-x","article-title":"Schizophrenia: a disorder of broken brain bioenergetics","volume":"27","author":"Henkel","year":"2022","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0121","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature."},{"key":"2026032106202889500_CIT0122","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"Do","year":"2009","journal-title":"Curr Opin Neurobiol."},{"key":"2026032106202889500_CIT0123","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.biopsych.2010.07.017","article-title":"Analyzing schizophrenia by DNA microarrays","volume":"69","author":"Horvath","year":"2011","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0124","doi-asserted-by":"crossref","article-title":"Proteomics as a tool for understanding schizophrenia","author":"Martins-de-Souza","DOI":"10.9758\/cpn.2011.9.3.95"},{"key":"2026032106202889500_CIT0125","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1371\/journal.pone.0003676","article-title":"Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression","volume":"3","author":"Ben-Shachar","year":"2008","journal-title":"PLoS One."},{"key":"2026032106202889500_CIT0126","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell."},{"key":"2026032106202889500_CIT0127","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.schres.2017.01.056","article-title":"Postmortem studies on mitochondria in schizophrenia","volume":"187","author":"Roberts","year":"2017","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0128","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mito.2020.11.009","article-title":"Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies","volume":"56","author":"Roberts","year":"2021","journal-title":"Mitochondrion"},{"key":"2026032106202889500_CIT0129","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1176\/appi.ajp.2020.19111210","article-title":"Diagnosis- and cell type-specific mitochondrial functional pathway signatures in schizophrenia and bipolar disorder","volume":"177","author":"Glausier","year":"2020","journal-title":"Am J Psychiatry."},{"key":"2026032106202889500_CIT0130","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.exger.2011.10.002","article-title":"Aging increases mitochondrial DNA damage and oxidative stress in liver of rhesus monkeys","volume":"47","author":"Castro Mdel","year":"2012","journal-title":"Exp Gerontol."},{"key":"2026032106202889500_CIT0131","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1111\/j.1742-4658.2009.07269.x","article-title":"Is there more to aging than mitochondrial DNA and reactive oxygen species","volume":"276","author":"Alexeyev","year":"2009","journal-title":"FEBS J."},{"key":"2026032106202889500_CIT0132","first-page":"1","article-title":"Oxidative stress in human aging and mitochondrial disease-consequences of defective mitochondrial respiration and impaired antioxidant enzyme system","volume-title":"Chin J Physiol.","author":"Wei","year":"2001"},{"key":"2026032106202889500_CIT0133","doi-asserted-by":"publisher","first-page":"31372","DOI":"10.1155\/JBB\/2006\/31372","article-title":"Mitochondrial oxidative damage in aging and Alzheimer\u2019s disease: implications for mitochondrially targeted antioxidant therapeutics","volume":"2006","author":"Reddy","year":"2006","journal-title":"J Biomed Biotechnol."},{"key":"2026032106202889500_CIT0134","doi-asserted-by":"publisher","first-page":"7991","DOI":"10.3390\/ijms24097991","article-title":"Mitochondrial dysfunction, altered mitochondrial oxygen, and energy metabolism associated with the pathogenesis of schizophrenia","volume":"24","author":"Fizikova","year":"2023","journal-title":"Int J Mol Sci ."},{"key":"2026032106202889500_CIT0135","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/biom10030384","article-title":"Oxidative-antioxidant imbalance and impaired glucose metabolism in schizophrenia","volume":"10","author":"Bryll","year":"2020","journal-title":"Biomolecules."},{"key":"2026032106202889500_CIT0136","doi-asserted-by":"publisher","first-page":"12916","DOI":"10.1186\/s12916-015-0310-y","article-title":"The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders","volume":"13","author":"Morris","year":"2015","journal-title":"BMC Med."},{"key":"2026032106202889500_CIT0137","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","article-title":"Synaptic energy use and supply","volume":"75","author":"Harris","year":"2012","journal-title":"Neuron."},{"key":"2026032106202889500_CIT0138","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0074-7742(04)59011-6","article-title":"Mitochondria, synaptic plasticity, and schizophrenia","volume":"59","author":"Ben-Shachar","year":"2004","journal-title":"Int Rev Neurobiol."},{"key":"2026032106202889500_CIT0139","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1172\/JCI64125","article-title":"The role of mitochondria in aging","volume":"123","author":"Bratic","year":"2013","journal-title":"J Clin Invest."},{"key":"2026032106202889500_CIT0140","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamapsychiatry.2013.2287","article-title":"In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy","volume":"71","author":"Du","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"2026032106202889500_CIT0141","doi-asserted-by":"publisher","first-page":"e967","DOI":"10.1038\/tp.2016.239","article-title":"Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study","volume":"6","author":"Rowland","year":"2016","journal-title":"Transl Psychiatry."},{"key":"2026032106202889500_CIT0142","doi-asserted-by":"publisher","first-page":"656459","DOI":"10.3389\/fpsyt.2021.656459","article-title":"Metabolite alterations in adults with schizophrenia, first degree relatives, and healthy controls: a multi-region 7T MRS study","volume":"12","author":"Wijtenburg","year":"2021","journal-title":"Front Psychiatry."},{"key":"2026032106202889500_CIT0143","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2023.11.013","article-title":"Lactate levels in the brain and blood of schizophrenia patients: a systematic review and meta-analysis","volume":"264","author":"Liu","year":"2024","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0144","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11920-023-01457-1","article-title":"Magnetic resonance spectroscopy studies of brain energy metabolism in schizophrenia: progression from prodrome to chronic psychosis","volume":"25","author":"Stein","year":"2023","journal-title":"Curr Psychiatry Rep."},{"key":"2026032106202889500_CIT0145","doi-asserted-by":"crossref","first-page":"20087","DOI":"10.1073\/pnas.1008189107","article-title":"High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A\/B ratio","volume":"107","author":"Ross","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2026032106202889500_CIT0146","doi-asserted-by":"publisher","first-page":"e037313","DOI":"10.1002\/alz.037313","article-title":"Determining the role of lactate metabolism on age-dependent memory decline and neurodegeneration in Drosophila melanogaster","volume":"16","author":"Frame","year":"2020","journal-title":"Alzheimer\u2019s Dementia."},{"key":"2026032106202889500_CIT0147","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","article-title":"Lactate in the brain: from metabolic end-product to signalling molecule","volume":"19","author":"Magistretti","year":"2018","journal-title":"Nat Rev Neurosci."},{"key":"2026032106202889500_CIT0148","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.3390\/ijms241713398","article-title":"Lactate metabolism, signaling, and function in brain development, synaptic plasticity, angiogenesis, and neurodegenerative diseases","volume":"24","author":"Wu","year":"2023","journal-title":"Int J Mol Sci ."},{"key":"2026032106202889500_CIT0149","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.brainresrev.2009.10.003","article-title":"The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking","volume":"63","author":"Hirrlinger","year":"2010","journal-title":"Brain Res Rev."},{"key":"2026032106202889500_CIT0150","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/(SICI)1097-4547(19990815)57:4&lt;417::AID-JNR1&gt;3.0.CO;2-N","article-title":"Astrocytes: glutamate producers for neurons","volume":"57","author":"Hertz","year":"1999","journal-title":"J Neurosci Res."},{"key":"2026032106202889500_CIT0151","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-94-007-2199-9_2","article-title":"Niacin status and genomic instability in bone marrow cells; mechanisms favoring the progression of leukemogenesis","volume":"56","author":"Kirkland","year":"2012","journal-title":"Subcell Biochem."},{"key":"2026032106202889500_CIT0152","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature25143","article-title":"Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity","volume":"552","author":"Sorrentino","year":"2017","journal-title":"Nature."},{"key":"2026032106202889500_CIT0153","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1056\/NEJMoa1616361","article-title":"NAD deficiency, congenital malformations, and niacin supplementation","volume":"377","author":"Shi","year":"2017","journal-title":"N Engl J Med."},{"key":"2026032106202889500_CIT0154","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/emmm.201302451","article-title":"SIRT1 and SIRT2: emerging targets in neurodegeneration","volume":"5","author":"Donmez","year":"2013","journal-title":"EMBO Mol Med."},{"key":"2026032106202889500_CIT0155","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","article-title":"Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases","volume":"123","author":"Kane","year":"2018","journal-title":"Circ Res."},{"key":"2026032106202889500_CIT0156","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/HNP.0000000000000461","article-title":"Nicotinamide adenine dinucleotide (NAD+) biosynthesis in the regulation of metabolism, aging, and neurodegeneration","volume":"35","author":"Ross","year":"2021","journal-title":"Holist Nurs Pract."},{"key":"2026032106202889500_CIT0157","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab."},{"key":"2026032106202889500_CIT0158","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1073\/pnas.1417921112","article-title":"vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2026032106202889500_CIT0159","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol."},{"key":"2026032106202889500_CIT0160","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","article-title":"Oxidative stress, aging, and diseases","volume":"13","author":"Liguori","year":"2018","journal-title":"Clin Interv Aging."},{"key":"2026032106202889500_CIT0161","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.celrep.2018.07.052","article-title":"Changes in glutathione redox potential are linked to A\u03b2(42)-induced neurotoxicity","volume":"24","author":"Stapper","year":"2018","journal-title":"Cell Rep."},{"key":"2026032106202889500_CIT0162","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cell.2018.02.008","article-title":"Impairment of an endothelial NAD(+)-H(2)S signaling network is a reversible cause of vascular aging","volume":"22","author":"Das","year":"2018","journal-title":"Cell."},{"key":"2026032106202889500_CIT0163","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/schbul\/sbw129","article-title":"Redox dysregulation in schizophrenia revealed by in vivo NAD+\/NADH measurement","volume":"43","author":"Kim","year":"2017","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0164","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1523\/JNEUROSCI.3857-09.2010","article-title":"Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors","volume":"30","author":"Steullet","year":"2010","journal-title":"J Neurosci."},{"key":"2026032106202889500_CIT0165","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.nbd.2006.01.003","article-title":"Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: relevance to schizophrenia","volume":"22","author":"Cabungcal","year":"2006","journal-title":"Neurobiol Dis."},{"key":"2026032106202889500_CIT0166","doi-asserted-by":"crossref","article-title":"Metabolism and functions of glutathione in brain","author":"Dringen","DOI":"10.1016\/S0301-0082(99)00060-X"},{"key":"2026032106202889500_CIT0167","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MCO.0000000000000134","article-title":"Glutathione redox imbalance in brain disorders","volume":"18","author":"Gu","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"2026032106202889500_CIT0168","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/ars.2007.1672","article-title":"NAD+\/NADH and NADP+\/NADPH in cellular functions and cell death: regulation and biological consequences","volume":"10","author":"Ying","year":"2008","journal-title":"Antioxid Redox Signal."},{"key":"2026032106202889500_CIT0169","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1089\/ars.2006.8.1865","article-title":"Redefining oxidative stress","volume":"8","author":"Jones","year":"2006","journal-title":"Antioxid Redox Signal."},{"key":"2026032106202889500_CIT0170","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ana.20476","article-title":"Fruit and vegetable consumption and cognitive decline in aging women","volume":"57","author":"Kang","year":"2005","journal-title":"Ann Neurol."},{"key":"2026032106202889500_CIT0171","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/brainsci13030490","article-title":"Oxidative stress biomarkers among schizophrenia inpatients","volume":"13","author":"Wiedlocha","year":"2023","journal-title":"Brain Sci."},{"key":"2026032106202889500_CIT0172","doi-asserted-by":"crossref","article-title":"Elevated plasma lipid peroxides at the onset of nonaffective psychosis","author":"Mahadik","DOI":"10.1016\/S0006-3223(97)00282-5"},{"key":"2026032106202889500_CIT0173","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1819.2009.02015.x","article-title":"Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile","volume":"63","author":"Pazvantoglu","year":"2009","journal-title":"Psychiatry Clin Neurosci."},{"key":"2026032106202889500_CIT0174","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.03.004","article-title":"Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes","volume":"137","author":"Mart\u00ednez-Cengotitabengoa","year":"2012","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0175","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur J Neurosci."},{"key":"2026032106202889500_CIT0176","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pnpbp.2018.08.006","article-title":"Antioxidant defense in schizophrenia and bipolar disorder: a meta-analysis of MRS studies of anterior cingulate glutathione","volume":"91","author":"Das","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"2026032106202889500_CIT0177","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/jpm13111526","article-title":"Schizophrenia and glutathione: a challenging story","volume":"13","author":"Carletti","year":"2023","journal-title":"J Pers Med."},{"key":"2026032106202889500_CIT0178","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1038\/s41380-020-00901-5","article-title":"A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia","volume":"26","author":"Coughlin","year":"2021","journal-title":"Mol Psychiatry."},{"key":"2026032106202889500_CIT0179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000202822","article-title":"Oxidative\/nitrative modifications of plasma proteins and thiols from patients with schizophrenia","volume":"59","author":"Dietrich-Muszalska","year":"2009","journal-title":"Neuropsychobiology."},{"key":"2026032106202889500_CIT0180","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","article-title":"Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients","volume":"33","author":"Raffa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"2026032106202889500_CIT0181","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pnpbp.2012.07.013","article-title":"Reduced antioxidant defense systems in schizophrenia and bipolar I disorder","volume":"39","author":"Raffa","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"2026032106202889500_CIT0182","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.psychres.2012.07.024","article-title":"Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: a 12-months follow-up study","volume":"200","author":"Ruiz-Litago","year":"2012","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0183","doi-asserted-by":"publisher","first-page":"e1215","DOI":"10.1038\/tp.2017.178","article-title":"Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry","volume":"7","author":"Nucifora","year":"2017","journal-title":"Transl Psychiatry."},{"key":"2026032106202889500_CIT0184","doi-asserted-by":"publisher","first-page":"113467","DOI":"10.1016\/j.psychres.2020.113467","article-title":"Predictive value of oxidative stress biomarkers in drug\u2011free patients with schizophrenia and schizo-affective disorder","volume":"293","author":"Guidara","year":"2020","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0185","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10517-015-3151-y","article-title":"Serum glutathione in patients with schizophrenia in dynamics of antipsychotic therapy","volume":"160","author":"Ivanova","year":"2015","journal-title":"Bull Exp Biol Med."},{"key":"2026032106202889500_CIT0186","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12888-014-0268-x","article-title":"Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition","volume":"14","author":"Gonzalez-Liencres","year":"2014","journal-title":"BMC Psychiatry."},{"key":"2026032106202889500_CIT0187","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.psychres.2013.01.023","article-title":"Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs","volume":"209","author":"Tsai","year":"2013","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0188","doi-asserted-by":"publisher","first-page":"537280","DOI":"10.3389\/fpsyt.2020.537280","article-title":"Insulin resistance and oxidative stress: in relation to cognitive function and psychopathology in drug-naive, first-episode drug-free schizophrenia","volume":"11","author":"Tao","year":"2020","journal-title":"Front Psychiatry."},{"key":"2026032106202889500_CIT0189","doi-asserted-by":"crossref","first-page":"113832","DOI":"10.1016\/j.psychres.2021.113832","article-title":"Investigating potential associations between neurocognition\/social cognition and oxidative stress in schizophrenia","volume":"298","author":"Cruz","year":"2021","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0190","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1186\/1471-244X-11-124","article-title":"Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients","volume":"11","author":"Raffa","year":"2011","journal-title":"BMC Psychiatry."},{"key":"2026032106202889500_CIT0191","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1515\/CCLM.2000.201","article-title":"Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients","volume":"38","author":"Altuntas","year":"2000","journal-title":"Clin Chem Lab Med."},{"key":"2026032106202889500_CIT0192","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/brainsci13030490","article-title":"Oxidative stress biomarkers among schizophrenia inpatients","volume-title":"Brain Sci","author":"Wi\u0119d\u0142ocha"},{"key":"2026032106202889500_CIT0193","doi-asserted-by":"crossref","first-page":"e1064","DOI":"10.1038\/tp.2017.30","article-title":"Erythrocyte glutathione levels as long-term predictor of transition to psychosis","volume":"7","author":"Lavoie","year":"2017","journal-title":"Transl Psychiatry."},{"key":"2026032106202889500_CIT0194","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1017\/S1461145711000617","article-title":"Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int J Neuropsychopharmacol."},{"key":"2026032106202889500_CIT0195","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11064-018-2521-z","article-title":"Magnetic resonance spectroscopy in schizophrenia: evidence for glutamatergic dysfunction and impaired energy metabolism","volume":"44","author":"Duarte","year":"2019","journal-title":"Neurochem Res."},{"key":"2026032106202889500_CIT0196","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41537-022-00293-1","article-title":"In vivo 7-Tesla MRI investigation of brain iron and its metabolic correlates in chronic schizophrenia","volume":"8","author":"Ravanfar","year":"2022","journal-title":"Schizophrenia (Heidelb)."},{"key":"2026032106202889500_CIT0197","doi-asserted-by":"publisher","first-page":"sgab006","DOI":"10.1093\/schizbullopen\/sgab006","article-title":"Glutathione levels and glutathione-glutamate correlation in patients with treatment-resistant schizophrenia","volume":"2","author":"Iwata","year":"2021","journal-title":"Schizophr Bull Open."},{"key":"2026032106202889500_CIT0198","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.psychres.2013.09.014","article-title":"Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia","volume":"210","author":"Samuelsson","year":"2013","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0199","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.plefa.2017.10.005","article-title":"Disturbed glutathione antioxidative defense is associated with structural brain changes in neuroleptic-na\u00efve first-episode psychosis patients","volume":"136","author":"Langbein","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"2026032106202889500_CIT0200","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.schres.2020.06.028","article-title":"A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: implications for studies of psychosis risk","volume":"226","author":"Sydnor","year":"2020","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0201","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ijnp\/pyx094","article-title":"Glutathione, the major redox regulator, in the prefrontal cortex of individuals at clinical high risk for psychosis","volume":"21","author":"Da Silva","year":"2018","journal-title":"Int J Neuropsychopharmacol."},{"key":"2026032106202889500_CIT0202","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1038\/s41598-018-24355-6","article-title":"Mitochondrial function in individuals at clinical high risk for psychosis","volume":"8","author":"Da Silva","year":"2018","journal-title":"Sci Rep."},{"key":"2026032106202889500_CIT0203","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/brainsci11070941","article-title":"Glutathione as a molecular marker of functional impairment in patients with at-risk mental state: 7-Tesla (1)H-MRS study","volume":"11","author":"Jeon","year":"2021","journal-title":"Brain Sci."},{"key":"2026032106202889500_CIT0204","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"Franceschi","year":"2007","journal-title":"Mech Ageing Dev."},{"key":"2026032106202889500_CIT0205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"key":"2026032106202889500_CIT0206","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"Muller","year":"2018","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0207","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00213-013-3382-4","article-title":"Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naive, first-episode schizophrenia","volume":"231","author":"Song","year":"2014","journal-title":"Psychopharmacology (Berl)."},{"key":"2026032106202889500_CIT0208","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0209","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jpsychires.2012.11.007","article-title":"Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells","volume":"47","author":"Gardiner","year":"2013","journal-title":"J Psychiatr Res."},{"key":"2026032106202889500_CIT0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.schres.2015.02.004","article-title":"Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients","volume":"164","author":"Pandey","year":"2015","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0211","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"2026032106202889500_CIT0212","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.psychres.2011.09.026","article-title":"Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia","volume":"196","author":"Tang","year":"2012","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0213","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/gps.5291","article-title":"Body mass index, residual psychotic symptoms, and inflammation associated with brain volume reduction in older patients with schizophrenia","volume":"35","author":"Tsai","year":"2020","journal-title":"Int J Geriatr Psychiatry."},{"key":"2026032106202889500_CIT0214","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fpsyt.2018.00438","article-title":"Putative astroglial dysfunction in schizophrenia: a meta-analysis of (1)H-MRS studies of medial prefrontal myo-inositol","volume":"9","author":"Das","year":"2018","journal-title":"Front Psychiatry."},{"key":"2026032106202889500_CIT0215","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/s0006-3223(98)00071-7","article-title":"Inositol levels are decreased in postmortem brain of schizophrenic patients","volume":"44","author":"Shimon","year":"1998","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0216","doi-asserted-by":"publisher","first-page":"3915703","DOI":"10.1155\/2016\/3915703","article-title":"Reduced gamma-aminobutyric acid and glutamate+glutamine levels in drug-naive patients with first-episode schizophrenia but not in those at ultrahigh risk","volume":"2016","author":"Wang","year":"2016","journal-title":"Neural Plast."},{"key":"2026032106202889500_CIT0217","doi-asserted-by":"publisher","first-page":"22333","DOI":"10.1038\/s41598-021-01773-7","article-title":"The trajectory of putative astroglial dysfunction in first episode schizophrenia: a longitudinal 7-Tesla MRS study","volume":"11","author":"Jeon","year":"2021","journal-title":"Sci Rep."},{"key":"2026032106202889500_CIT0218","doi-asserted-by":"publisher","first-page":"sgaa072","DOI":"10.1093\/schizbullopen\/sgaa072","article-title":"Progressive changes in glutamate concentration in early stages of schizophrenia: a longitudinal 7-Tesla MRS study","volume":"2","author":"Jeon","year":"2021","journal-title":"Schizophr Bull Open."},{"key":"2026032106202889500_CIT0219","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.11817\/j.issn.1672-7347.2021.200240","article-title":"Abnormal neurobiochemical metabolites in the first- episode schizophrenia and clinical high-risk population","volume":"46","author":"Ouyang","year":"2021","journal-title":"Zhong nan da xue xue bao. Yi xue ban = J Central South Univ Med Sci."},{"key":"2026032106202889500_CIT0220","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0920-9964(02)00339-0","article-title":"Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia","volume":"57","author":"Rajkowska","year":"2002","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0221","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.biopsych.2017.08.022","article-title":"vivo brain glycine and glutamate concentrations in patients with first-episode psychosis measured by echo time-averaged proton magnetic resonance spectroscopy at 4T","volume":"83","author":"Kim","year":"2018","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0222","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/schbul\/sbv118","article-title":"Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: a proton magnetic resonance spectroscopy study with implications for glial dysfunction","volume":"42","author":"Plitman","year":"2016","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0223","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0920-9964(01)00155-4","article-title":"Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation","volume":"52","author":"Auer","year":"2001","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0224","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbi.2021.11.019","article-title":"Inflammatory subtypes in antipsychotic-naive first-episode schizophrenia are associated with altered brain morphology and topological organization","volume":"100","author":"Hoang","year":"2022","journal-title":"Brain Behav Immun."},{"key":"2026032106202889500_CIT0225","doi-asserted-by":"publisher","first-page":"100459","DOI":"10.1016\/j.bbih.2022.100459","article-title":"Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders","volume":"22","author":"Zhang","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"2026032106202889500_CIT0226","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hbm.22159","article-title":"Cross-sectional and longitudinal association of body mass index and brain volume","volume":"35","author":"Bobb","year":"2014","journal-title":"Hum Brain Mapp."},{"key":"2026032106202889500_CIT0227","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/gps.5291","article-title":"Body mass index, residual psychotic symptoms, and inflammation associated with brain volume reduction in older patients with schizophrenia","volume":"35","author":"Tsai","year":"2020","journal-title":"Int J Geriatr Psychiatry."},{"key":"2026032106202889500_CIT0228","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"M\u00fcller","year":"2018","journal-title":"Schizophr Bull."},{"key":"2026032106202889500_CIT0229","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psychres.2013.01.023","article-title":"Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs","volume":"209","author":"Tsai","year":"2013","journal-title":"Psychiatry Res."},{"key":"2026032106202889500_CIT0230","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch Gen Psychiatry."},{"key":"2026032106202889500_CIT0231","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.biopsych.2004.02.002","article-title":"Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study","volume":"54","author":"Erratum","year":"2004","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0232","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1192\/bjp.162.1.80","article-title":"The influence of age and sex on the onset and early course of schizophrenia","volume":"162","author":"H\u00e4fner","year":"1993","journal-title":"Br J Psychiatry."},{"key":"2026032106202889500_CIT0233","doi-asserted-by":"publisher","first-page":"615356","DOI":"10.1155\/2015\/615356","article-title":"A role for estrogen in schizophrenia: clinical and preclinical findings","volume":"2015","author":"Gogos","year":"2015","journal-title":"Int J Endocrinol"},{"key":"2026032106202889500_CIT0234","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/ijms22010373","article-title":"The role of estrogen receptors and their signaling across psychiatric disorders","volume":"22","author":"Hwang","year":"2020","journal-title":"Int J Mol Sci."},{"key":"2026032106202889500_CIT0235","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11154-011-9184-2","article-title":"Sex steroids and schizophrenia","volume":"13","author":"Markham","year":"2012","journal-title":"Rev Endocr Metab Disord."},{"key":"2026032106202889500_CIT0236","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neurobiolaging.2019.05.020","article-title":"Sex differences in brain aging and predictors of neurodegeneration in cognitively healthy older adults","volume":"81","author":"Armstrong","year":"2019","journal-title":"Neurobiol Aging."},{"key":"2026032106202889500_CIT0237","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biopsych.2005.03.043","article-title":"Cortical thinning in cingulate and occipital cortices in first episode schizophrenia","volume":"58","author":"Narr","year":"2005","journal-title":"Biol Psychiatry."},{"key":"2026032106202889500_CIT0238","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1176\/ajp.152.5.704","article-title":"Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia","volume":"152","author":"Flaum","year":"1995","journal-title":"Am J Psychiatry."},{"key":"2026032106202889500_CIT0239","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fnmol.2018.00197","article-title":"Sex differences in psychiatric disease: a focus on the glutamate system","volume":"11","author":"Wickens","year":"2018","journal-title":"Front Mol Neurosci."},{"key":"2026032106202889500_CIT0240","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/ph17020237","article-title":"Use of quantitative electroencephalography to inform age- and sex-related differences in NMDA receptor function following MK-801 administration","volume":"17","author":"Holter","year":"2024","journal-title":"Pharmaceuticals (Basel)."},{"key":"2026032106202889500_CIT0241","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuroscience.2012.10.026","article-title":"Acute N-methyl-D-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats","volume":"228","author":"Feinstein","year":"2013","journal-title":"Neuroscience."},{"key":"2026032106202889500_CIT0242","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.0065-1591.2000.0ap25.x","article-title":"Sex differences in schizophrenia, a review of the literature","volume":"401","author":"Leung","year":"2000","journal-title":"Acta Psychiatr Scand Suppl."},{"key":"2026032106202889500_CIT0243","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1037\/\/0021-843x.99.2.138","article-title":"Gender, social competence, and symptomatology in schizophrenia: a longitudinal analysis","volume":"99","author":"Mueser","year":"1990","journal-title":"J Abnorm Psychol."},{"key":"2026032106202889500_CIT0244","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.schres.2008.06.012","article-title":"Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia","volume":"104","author":"Bauer","year":"2008","journal-title":"Schizophr Res."},{"key":"2026032106202889500_CIT0245","doi-asserted-by":"publisher","first-page":"101009","DOI":"10.1016\/j.yfrne.2022.101009","article-title":"Metabolic hormones mediate cognition","volume":"66","author":"Ghosh-Swaby","year":"2022","journal-title":"Front Neuroendocrinol."},{"key":"2026032106202889500_CIT0246","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21315\/mjms2018.25.4.3","article-title":"Hormonal influences on cognitive function","volume":"25","author":"Ali","year":"2018","journal-title":"Malays J Med Sci"},{"key":"2026032106202889500_CIT0247","doi-asserted-by":"publisher","first-page":"256","DOI":"10.14336\/ad.2014.0500256","article-title":"Accelerated aging in schizophrenia patients: the potential role of oxidative stress","volume":"5","author":"Okusaga","year":"2014","journal-title":"Aging Dis"},{"key":"2026032106202889500_CIT0248","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0962280214547150","article-title":"Accelerated longitudinal designs: an overview of modelling, power, costs and handling missing data","volume":"26","author":"Galbraith","year":"2017","journal-title":"Stat Methods Med Res."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/2\/sbaf099\/63674485\/sbaf099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/2\/sbaf099\/63674485\/sbaf099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T10:20:44Z","timestamp":1774088444000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbaf099\/8186963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,6]]},"references-count":248,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,6]]},"published-print":{"date-parts":[[2026,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbaf099","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,7,6]]},"article-number":"sbaf099"}}